182 related articles for article (PubMed ID: 3698718)
1. The use of dihydroergotamine and heparin in the prophylaxis of deep venous thrombosis.
Comerota AJ; White JV
Chest; 1986 May; 89(5 Suppl):389S-395S. PubMed ID: 3698718
[TBL] [Abstract][Full Text] [Related]
2. Combined dihydroergotamine and heparin prophylaxis of postoperative deep vein thrombosis: proposed mechanism of action.
Comerota AJ; Stewart GJ; White JV
Am J Surg; 1985 Oct; 150(4A):39-44. PubMed ID: 3901791
[TBL] [Abstract][Full Text] [Related]
3. A fixed-dose combination of low molecular weight heparin with dihydroergotamine versus adjusted-dose unfractionated heparin in the prevention of deep-vein thrombosis after total hip replacement.
Horbach T; Wolf H; Michaelis HC; Wagner W; Hoffmann A; Schmidt A; Beck H
Thromb Haemost; 1996 Feb; 75(2):246-50. PubMed ID: 8815569
[TBL] [Abstract][Full Text] [Related]
4. Review of the Multicenter Trial Committee report: a prospective, randomized study on the prophylaxis of postoperative deep venous thrombosis.
Comerota AJ
Pharmacotherapy; 1986; 6(4 Pt 2):18S-22S. PubMed ID: 3534803
[TBL] [Abstract][Full Text] [Related]
5. Low molecular weight heparin plus dihydroergotamine for prophylaxis of postoperative deep vein thrombosis.
Sasahara AA; Koppenhagen K; Häring R; Welzel D; Wolf H
Br J Surg; 1986 Sep; 73(9):697-700. PubMed ID: 3530367
[TBL] [Abstract][Full Text] [Related]
6. Prophylactic efficacy of low-dose dihydroergotamine and heparin in postoperative deep venous thrombosis following intra-abdominal operations.
J Vasc Surg; 1984 Sep; 1(5):608-16. PubMed ID: 6389909
[TBL] [Abstract][Full Text] [Related]
7. Prophylaxis for postoperative deep-vein thrombosis. Synergistic effect of heparin and dihydroergotamine.
Kakkar VV; Stamatakis JD; Bentley PG; Lawrence D; de Haas HA; Ward VP
JAMA; 1979 Jan; 241(1):39-42. PubMed ID: 758493
[TBL] [Abstract][Full Text] [Related]
8. Operative venodilation: a previously unsuspected factor in the cause of postoperative deep vein thrombosis.
Comerota AJ; Stewart GJ; Alburger PD; Smalley K; White JV
Surgery; 1989 Aug; 106(2):301-8: discussion 308-9. PubMed ID: 2763031
[TBL] [Abstract][Full Text] [Related]
9. Combination dihydroergotamine mesylate and heparin sodium with lidocaine HCl. Pharmacokinetics, mechanism of action, clinical efficacy, and adverse effects.
Barone JA; Raia JJ; Levy DB
Pharmacotherapy; 1986; 6(4 Pt 2):3S-11S. PubMed ID: 3534804
[TBL] [Abstract][Full Text] [Related]
10. Prevention of postoperative deep vein thrombosis by a combination of subcutaneous heparin with subcutaneous dihydroergotamine or oral sulphinpyrazone.
Veth G; Meuwissen OJ; van Houwelingen HC; Sixma JJ
Thromb Haemost; 1985 Oct; 54(3):570-3. PubMed ID: 4089792
[TBL] [Abstract][Full Text] [Related]
11. A prospective randomized trial of low molecular weight heparin-DHE and conventional heparin-DHE (with acenocoumarol) in patients undergoing gynaecological surgery.
Steiner RA; Keller K; Lüscher T; Schreiner WE
Arch Gynecol Obstet; 1989; 244(3):141-50. PubMed ID: 2544152
[TBL] [Abstract][Full Text] [Related]
12. Dihydroergotamine/heparin in the prevention of deep-vein thrombosis after total hip replacement. A controlled, prospective, randomized multicenter trial.
Beisaw NE; Comerota AJ; Groth HE; Merli GJ; Weitz HH; Zimmerman RC; Diserio FJ; Sasahara AA
J Bone Joint Surg Am; 1988 Jan; 70(1):2-10. PubMed ID: 3275673
[TBL] [Abstract][Full Text] [Related]
13. Dihydroergotamine/heparin in the prevention of deep-vein thrombosis after total hip replacement.
J Bone Joint Surg Am; 1989 Feb; 71(2):311-2. PubMed ID: 2918019
[No Abstract] [Full Text] [Related]
14. Prevention of postoperative deep vein thrombosis by one daily injection of low molecular weight heparin and dihydroergotamine.
Baumgartner A; Jacot N; Moser G; Krähenbühl B
Vasa; 1989; 18(2):152-6. PubMed ID: 2545054
[TBL] [Abstract][Full Text] [Related]
15. United States trial of dihydroergotamine and heparin prophylaxis of deep vein thrombosis.
DiSerio FJ; Sasahara AA
Am J Surg; 1985 Oct; 150(4A):25-32. PubMed ID: 3901790
[TBL] [Abstract][Full Text] [Related]
16. Should dihydroergotamine-heparin be used for prevention of postoperative thromboembolism?
Emory CE; Cuddy PG
Drug Intell Clin Pharm; 1987 May; 21(5):427-31. PubMed ID: 3107960
[TBL] [Abstract][Full Text] [Related]
17. Prevention of deep vein thrombosis in neurosurgical patients: a prospective double-blind comparison of two prophylactic regimen.
Voth D; Schwarz M; Hahn K; Dei-Anang K; al Butmeh S; Wolf H
Neurosurg Rev; 1992; 15(4):289-94. PubMed ID: 1336131
[TBL] [Abstract][Full Text] [Related]
18. Heparin/dihydroergotamine for venous thrombosis prophylaxis: comparison of low-dose heparin and low molecular weight heparin in hip surgery.
Lassen MR; Borris LC; Christiansen HM; Møller-Larsen F; Knudsen VE; Boris P; Nehen AM; de Carvalho A; Jurik AG; Nielsen BW
Br J Surg; 1988 Jul; 75(7):686-9. PubMed ID: 2843255
[TBL] [Abstract][Full Text] [Related]
19. [Different effectiveness of two preparations of low molecular weight heparin in patients with elective hip joint replacement].
Weber U; Koppenhagen K; Mälzer H; Matthes M
Langenbecks Arch Chir; 1991; 376(3):147-51. PubMed ID: 1651434
[TBL] [Abstract][Full Text] [Related]
20. Dihydroergotamine-heparin prophylaxis of postoperative deep vein thrombosis. A multicenter trial. The Multicenter Trial Committee.
JAMA; 1984 Jun; 251(22):2960-6. PubMed ID: 6371278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
